Barrett Katz, Chief Medical Officer at Viridian Therapeutics, Inc.\DE (VRDN), sold 120,000 shares at $33.04 ($4.2M) on 2023-01-09, disclosed to the SEC on 2023-01-11.
Open-market sale of $4.2M VRDN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.04 | 12,623 | $417K | 10.0% |
| 2 | $33.04 | 12,623 | $417K | 10.0% |
| 3 | $35.30 | 47,377 | $1.7M | 40.0% |
| 4 | $35.30 | 47,377 | $1.7M | 40.0% |
| Total | $34.82 avg | 120,000 | $4.2M | 100% |